# Ligand Pharmaceuticals Incorporated (LGND): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/lgnd for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $305.69 USD |
| Market Cap | $6.09B |
| P/E (TTM) | 33.55 |
| EPS (TTM) | $9.11 |
| 52-Week Range | $175.89 – $326.63 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Special |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | — / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2007-04-03 | $9.3575 | 2007-04-19 |

Full history: https://www.dividenddata.com/stocks/lgnd/dividend

## Frequently Asked Questions

### What does Ligand Pharmaceuticals Incorporated do?

Ligand Pharmaceuticals Incorporated (LGND) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is LGND's market cap?

Ligand Pharmaceuticals Incorporated (LGND) has a market capitalization of approximately $6.09 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does LGND pay a dividend?

No, Ligand Pharmaceuticals Incorporated (LGND) is not currently paying a dividend. Its last ex-dividend date was July 2, 2010 ($0.46 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### How often did LGND pay dividends?

Ligand Pharmaceuticals Incorporated paid dividends special until 2010; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is LGND's payout ratio?

Ligand Pharmaceuticals Incorporated's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/lgnd
- Dividend history & safety: https://www.dividenddata.com/stocks/lgnd/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/lgnd/earnings
- Financial statements: https://www.dividenddata.com/stocks/lgnd/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/lgnd/valuation
- Peer comparison: https://www.dividenddata.com/stocks/lgnd/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.